Cite
HARVARD Citation
Christensen, H. et al. (n.d.). DOP57 GLP-1 based therapies and risk of Inflammatory Bowel Disease: real world evidence from a nationwide cohort study. Journal of Crohn's and colitis. p. i128. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Christensen, H. et al. (n.d.). DOP57 GLP-1 based therapies and risk of Inflammatory Bowel Disease: real world evidence from a nationwide cohort study. Journal of Crohn's and colitis. p. i128. [Online].